Showing results (21-30 of 157) with videos related to
Sort By:
Pageof 16
Blood|May 19, 2021
CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopagFrancesca Basso-Valentina, Gabriel Levy, Leila N Varghese, et al.Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Myeloproliferative neoplasms: JAK2 signaling pathway as a central target for therapyFlorence Pasquier, Xenia Cabagnols, Lise Secardin, et al.Blood Cancer Journal|May 12, 2026
Impaired iron balance and erythrocytosis: a complex relationshipBenoît Gendrot, Carole Peyssonnaux, Isabelle Plo, et al.Nature Communications|September 28, 2020
Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPNCamélia Benlabiod, Maira da Costa Cacemiro, Audrey Nédélec, et al.Cell Reports|September 12, 2019
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid TumorsMalik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.Oncoimmunology|September 14, 2020
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosisOliver Kepp, Peng Liu, Liwei Zhao, et al.Molecular Pharmacology|April 21, 2010
Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptorsCaroline Marty, Richard D YeBulletin Du Cancer|August 7, 2016
[Not Available]Matthieu Mosca, Gaëlle Vertenoeil, Katte Rao Toppaldoddi, et al.Haematologica|October 24, 2024
New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease?Florence Pasquier, Jean Pegliasco, Jean-Edouard Martin, et al.Blood|November 8, 2019
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasmsChristian A Di Buduo, Vittorio Abbonante, Caroline Marty, et al.Pageof 16